Arovella Therapeutics Webinar on iNKT Cell Therapy
Company Announcements

Arovella Therapeutics Webinar on iNKT Cell Therapy

Arovella Therapeutics Limited (AU:ALA) has released an update.

Arovella Therapeutics Ltd, known for its innovative iNKT cell therapy platform, has announced an investor webinar to discuss recent advancements and future plans following a successful pre-IND meeting with the FDA. The webinar, led by CEO Dr. Michael Baker, will provide insights into the company’s next steps for ALA-101 and its potential in treating CD19-positive blood cancers. Interested parties can join the webinar on Wednesday, 18 September 2024, and access the recording afterward on the company’s website and social channels.

For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Expands with New Share Issue and Cancer Therapies
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Lists New Securities on ASX
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Unveils Promising Cancer Therapy Platform
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App